Tudor Investment Corp
RIGL icon

Tudor Investment Corp’s Rigel Pharmaceuticals RIGL Stock Holding History

Tudor Investment Corp’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,397
Closed -$625K – 2746
2021
Q2 		$625K Buy
+14,397
New +$544K 0.01% 1082
2020
Q1 		– Sell
-13,901
Closed -$297K – 1283
2019
Q4 		$297K Sell
13,901
-10,508
-43% -$216K 0.01% 873
2019
Q3 		$456K Buy
24,409
+6,793
+39% +$140K 0.02% 738
2019
Q2 		$460K Buy
17,616
+9,078
+106% +$205K 0.01% 738
2019
Q1 		$219K Buy
+8,538
New +$195K 0.01% 968
2018
Q1 		– Sell
-5,581
Closed -$217K – 1199
2017
Q4 		$217K Buy
+5,581
New +$212K 0.01% 941
2016
Q4 		– Sell
-4,224
Closed -$155K – 1571
2016
Q3 		$155K Buy
4,224
+1,299
+44% +$37.2K ﹤0.01% 1295
2016
Q2 		$65K Hold
2,925
– – ﹤0.01% 1542
2016
Q1 		$61K Buy
2,925
+814
+39% +$20.1K ﹤0.01% 1644
2015
Q4 		$64K Buy
2,111
+220
+12% +$6.67K ﹤0.01% 1564
2015
Q3 		$47K Buy
1,891
+20
+1% +$597 ﹤0.01% 1478
2015
Q2 		$60K Buy
1,871
+490
+35% +$18.7K ﹤0.01% 1438
2015
Q1 		$49K Buy
+1,381
New +$37.9K ﹤0.01% 1405
2014
Q3 		– Sell
-1,195
Closed -$43K – 1474
2014
Q2 		$43K Buy
1,195
+26
+2% +$884 ﹤0.01% 1127
2014
Q1 		$45K Buy
+1,169
New +$41.7K ﹤0.01% 1152

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tudor Investment Corp's RIGL Position: Q3 2021 in Review

Tudor Investment Corp sold out of Rigel Pharmaceuticals (RIGL) in Q3 2021, closing a stake of 14,397 shares — an estimated $625K sold.

Tudor Investment Corp first reported a position in RIGL in Q1 2014 and held it in 15 quarters. The position peaked at $625K in Q2 2021. 163 funds tracked by Wall St. Rank hold RIGL as of Q3 2021.

  • Tudor Investment Corp reported no remaining Rigel Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Tudor Investment Corp sold 14,397 Rigel Pharmaceuticals shares in Q3 2021, an estimated $625K.
  • Tudor Investment Corp first reported a position in Rigel Pharmaceuticals in Q1 2014 and held it in 15 quarters.
  • Tudor Investment Corp's Rigel Pharmaceuticals position peaked at $625K in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2021.

Based on Tudor Investment Corp's 13F filing for Q3 2021, filed 15 Nov 2021.